Quidel Corp. (QDEL) PT Raised to $27 at Barclays; Reiterates Overweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Tweet
Share
E-mailGet Alerts QDEL Hot Sheet
Price: $13.48 -4.26%
Rating Summary:
7 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 11 | New: 48
Rating Summary:
7 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 11 | New: 48
Join SI Premium – FREE
Barclays raised its price target on Quidel Corp. (NASDAQ: QDEL) to $27.00 (from $26.00) while maintaining a Overweight rating. QDEL reported 1Q revenues of $73.7 million, beating estimates of $62.4 million by 18%. The beat was driven by a more aggressive-than-expected flu season.
Analyst Jack Meehan believes that the company's innovation in point-of-care testing fits well into broader trends related to healthcare consumerism.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- argenx SE (ARGX) PT Raised to $861 at Baird
- Winnebago Industries (WGO) PT Lowered to $36 at StoneX
- Tractor Supply Company (TSCO) PT Raised to $34 at Truist Securities
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst PT ChangeRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
